Skip to main content
. 2022 Jul 12;10(7):1672. doi: 10.3390/biomedicines10071672

Figure 4.

Figure 4

Cell apoptosis by Annexin V- FITC/ propidium iodide (PI) dual stain. Viability (V): (A) 83.50%; (B) 94.72%; (C) 68.79%; (D) 87.90%; Incipient apoptosis (IA): (A) 0.00%; (B) 0.54%; (C) 0.005%; (D) 0.025%; Late apoptosis (LA): (A) 0.00%; (B) 0.49%; (C) 0.07%; (D) 0.22%; Necrosis (n): (A) 17.12%; (B) 4.23%; (C) 31.13%; (D) 11.85%. Legend: A, non-malignant prostate tissue adjacent to nodular hyperplastic tissue; B, adenoleiomyoma prostate tissue, chronic inflammation hyperplasia; C, malignant prostate tumor tissue; D, benign prostatic tissue hyperplasia.